GSK2110183

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GSK2110183, covering 2012-03-26 to 2020-09-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis [Phase 2]